LAC-B
LIVE

Serial Number

79437745

Owner

KOWA COMPANY, LTD.

Filing Date

Jul 23, 2025

Add to watchlist:

No watchlists yet
View on USPTO

LAC-B Trademark

Serial Number: 79437745

LAC-B is a trademark filed by KOWA COMPANY, LTD. on July 23, 2025. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

KOWA COMPANY, LTD. (3 trademarks)

6-29, Nishiki 3-chome,

Entity Type: 03

Trademark Details

Filing Date

July 23, 2025

Registration Date

Not Registered

Goods & Services

Pharmaceutical preparations for the treatment of cardiovascular disorders and metabolic disorders; pharmaceutical preparations for the treatment of glaucoma and ocular hypertension; pharmaceutical preparations for the treatment of corneal endothelial disorder; sanitary preparations for medical use; pharmaceutical preparations for the treatment of conditions and diseases of the circulatory system; pharmaceutical preparations for treatment or prevention of COVID-19, coronavirus disease, and respiratory diseases and disorders; antivirals for treatment or prevention of COVID-19, coronavirus disease, and respiratory diseases and disorders; hand-sanitizing preparations; antimicrobials for dermatologic use; disinfectants for sanitary purposes; household disinfectants; pharmaceutical and biological preparations for the treatment of diseases of the central nervous system, peripheral nervous system, sensory organs, the circulatory system, respiratory system, and the digestive system; pharmaceutical substances for the treatment of dermatological diseases, allergies and urogenital or anal conditions; pharmaceutical preparations, namely, amino acid for medical or veterinary purposes; pharmaceutical preparations for the prevention and treatment of disorders of the metabolic system; topical and oral antibiotics; pharmaceutical preparations for use in chemotherapy; chemotherapeutic agents having antineoplastic activity; crude drugs, namely, medicines made of rootstock, bark, leaves, fruits, seeds, rhinoceros' horn, musk or bear's gall, used for the treatment of pain, cold, fever, anemia, and for diuretics, astringents; antibiotic preparations for human use; anti-inflammatory agents, namely, topical preparations in the form of gels and salves, adhesive skin patches, liquid formulations, cream and sprays, all for relieving pain; analgesics; dietary supplements for human beings; live biotherapeutic product for medical purposes; biological preparations for medical purposes, namely probiotic preparations

Filing History

CORRECTION TRANSACTION RECEIVED FROM IB
Mar 5, 2026 CRCV
REFUSAL PROCESSED BY IB
Feb 19, 2026 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jan 31, 2026 RFCS
REFUSAL PROCESSED BY MPU
Jan 31, 2026 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 3, 2026 RFCR
NON-FINAL ACTION WRITTEN
Jan 2, 2026 CNRT
ASSIGNED TO EXAMINER
Dec 17, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Dec 16, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 16, 2025 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Dec 15, 2025 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Nov 27, 2025 REPR